Related Experiment Videos

DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets

V Devauchelle1, S Marion, N Cagnard

  • 1Institut Cochin, Paris, France.

Genes and Immunity
|October 22, 2004
PubMed

Insights

Researchers identified a molecular signature for rheumatoid arthritis (RA) by comparing gene expression in synovial tissues of RA and osteoarthritis (OA) patients. This discovery aids in developing diagnostic tools and potential therapeutic targets for RA.

Area of Science:

  • Molecular biology
  • Genomics
  • Immunology

Background:

  • Rheumatoid arthritis (RA) and osteoarthritis (OA) are distinct joint diseases with different underlying pathologies.
  • Accurate molecular differentiation between RA and OA is crucial for targeted treatment and prognosis.
  • Current diagnostic methods may not fully capture the molecular complexity of RA.

Purpose of the Study:

  • To establish a molecular signature differentiating rheumatoid arthritis (RA) from osteoarthritis (OA).
  • To identify novel genes and biological pathways implicated in RA pathogenesis.
  • To lay the groundwork for developing advanced diagnostic and prognostic tools for RA.

Main Methods:

  • Gene expression profiling using microarray technology on synovial tissue samples from RA and OA patients.
  • Selection of a gene set (63 genes) based on differential expression between RA and OA.
  • Validation of selected gene expression using quantitative PCR (qPCR) and quantitative RT-PCR.
  • Classification analysis of RA and OA patients based on the expression profiles of known genes.

Main Results:

  • A set of 63 differentially expressed genes was identified between RA and OA synovial tissues.
  • Expression profiles of 48 known genes enabled accurate classification of RA and OA patients.
  • Quantitative PCR confirmed the differential expression of key genes.
  • Analysis revealed dysregulated biological pathways and novel candidate genes involved in RA.

Conclusions:

  • A distinct molecular signature for rheumatoid arthritis (RA) has been identified.
  • The identified gene expression patterns can aid in the development of diagnostic and prognostic tools for RA.
  • Novel genes and pathways implicated in RA pathogenesis offer potential therapeutic targets.

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...